1. Home
  2. SGMT vs EFSI Comparison

SGMT vs EFSI Comparison

Compare SGMT & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • EFSI
  • Stock Information
  • Founded
  • SGMT 2006
  • EFSI 1881
  • Country
  • SGMT United States
  • EFSI United States
  • Employees
  • SGMT N/A
  • EFSI N/A
  • Industry
  • SGMT
  • EFSI Major Banks
  • Sector
  • SGMT
  • EFSI Finance
  • Exchange
  • SGMT Nasdaq
  • EFSI Nasdaq
  • Market Cap
  • SGMT 238.7M
  • EFSI 201.2M
  • IPO Year
  • SGMT 2023
  • EFSI N/A
  • Fundamental
  • Price
  • SGMT $8.52
  • EFSI $36.21
  • Analyst Decision
  • SGMT Strong Buy
  • EFSI Strong Buy
  • Analyst Count
  • SGMT 8
  • EFSI 2
  • Target Price
  • SGMT $26.88
  • EFSI $39.50
  • AVG Volume (30 Days)
  • SGMT 655.0K
  • EFSI 9.2K
  • Earning Date
  • SGMT 11-13-2025
  • EFSI 10-23-2025
  • Dividend Yield
  • SGMT N/A
  • EFSI 3.39%
  • EPS Growth
  • SGMT N/A
  • EFSI N/A
  • EPS
  • SGMT N/A
  • EFSI 2.13
  • Revenue
  • SGMT N/A
  • EFSI $66,122,000.00
  • Revenue This Year
  • SGMT N/A
  • EFSI N/A
  • Revenue Next Year
  • SGMT N/A
  • EFSI $28.84
  • P/E Ratio
  • SGMT N/A
  • EFSI $16.98
  • Revenue Growth
  • SGMT N/A
  • EFSI 3.18
  • 52 Week Low
  • SGMT $1.73
  • EFSI $28.70
  • 52 Week High
  • SGMT $11.41
  • EFSI $40.03
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 57.50
  • EFSI 43.62
  • Support Level
  • SGMT $8.05
  • EFSI $36.02
  • Resistance Level
  • SGMT $9.46
  • EFSI $38.94
  • Average True Range (ATR)
  • SGMT 0.65
  • EFSI 0.80
  • MACD
  • SGMT 0.07
  • EFSI -0.07
  • Stochastic Oscillator
  • SGMT 59.31
  • EFSI 23.74

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About EFSI Eagle Financial Services Inc Common Stock

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

Share on Social Networks: